GPNMB protects against obesity-related metabolic disorders by attenuating macrophage-derived inflammation in white adipose tissue through CD44 receptor-dependent mechanism

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Novel insights into metabolic strategies to treat cardiovascular disease Lipid Metabolism, Metabolic Syndrome, Diabetes ESC Premium Access ESC Congress 2021 - The Digital Experience

ESC 365 is supported by

ESC 365 is supported by